Nolvadex 20 Beligas: Compound Profile
Nolvadex 20 is a pharmaceutical-grade tamoxifen citrate formulation manufactured by Beligas, containing 20mg per tablet for laboratory research applications. Tamoxifen citrate is a well-established non-steroidal selective estrogen receptor modulator (SERM) extensively studied in preclinical and clinical research settings. This compound exhibits dual functionality as both an estrogen receptor antagonist and agonist, depending on tissue type, making it a valuable reference standard for researchers investigating estrogen pathway modulation. The Beligas formulation provides consistent dosing for controlled experimental protocols examining SERM mechanisms and tissue-selective estrogen receptor interactions.
Laboratory Applications
Researchers at Stroid UK Shop utilise tamoxifen citrate to investigate estrogen receptor signalling pathways in breast cancer cell lines, bone metabolism studies, and endocrine system research. The compound’s well-documented pharmacological profile makes it an essential tool for comparative studies alongside other compounds available in our aromatase inhibitor collection. Research protocols often examine tamoxifen’s competitive antagonism at estrogen receptors in mammary tissue while simultaneously studying its agonistic effects in bone and endometrial models. Scientists investigating selective androgen receptor modulators frequently include tamoxifen as a control compound for understanding selective receptor modulation mechanisms. Additionally, researchers examining peptide interactions with hormone pathways utilise this compound to establish baseline estrogen receptor activity in experimental models.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Tamoxifen Citrate |
| Dosage | 20mg per tablet |
| Manufacturer | Beligas |
| CAS Number | 54965-24-1 |
| Molecular Formula | C₃₂H₃₇NO₈ |
| Molecular Weight | 563.64 g/mol |
| Storage | Room temperature, protect from light |
| Intended Use | Laboratory research only |
Research Compliance
This tamoxifen citrate product is manufactured exclusively for in-vitro laboratory research and educational purposes. Not approved for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure appropriate institutional approvals and safety protocols are in place before commencing experimental work.
